MX2017010304A - Composiciones farmaceuticas que comprenden meloxicam. - Google Patents

Composiciones farmaceuticas que comprenden meloxicam.

Info

Publication number
MX2017010304A
MX2017010304A MX2017010304A MX2017010304A MX2017010304A MX 2017010304 A MX2017010304 A MX 2017010304A MX 2017010304 A MX2017010304 A MX 2017010304A MX 2017010304 A MX2017010304 A MX 2017010304A MX 2017010304 A MX2017010304 A MX 2017010304A
Authority
MX
Mexico
Prior art keywords
meloxicam
pharmaceutical compositions
compositions
nsaid
pharmacokinetics
Prior art date
Application number
MX2017010304A
Other languages
English (en)
Inventor
Tabuteau Herriot
Original Assignee
Axsome Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axsome Therapeutics Inc filed Critical Axsome Therapeutics Inc
Priority claimed from PCT/US2016/026991 external-priority patent/WO2016131067A2/en
Publication of MX2017010304A publication Critical patent/MX2017010304A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

En la presente se describen composiciones que comprenden un AINE, tal como meloxicam en combinación con una ciclodextrina y/o un carbonato o un bicarbonato. Estas composiciones se pueden administrar por vía oral, por ejemplo, para mejorar la biodisponibilidad o farmacocinética del AINE para el tratamiento de afecciones, tales como el dolor.
MX2017010304A 2015-11-25 2016-04-11 Composiciones farmaceuticas que comprenden meloxicam. MX2017010304A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562259993P 2015-11-25 2015-11-25
PCT/US2016/026991 WO2016131067A2 (en) 2015-02-10 2016-04-11 Pharmaceutical compositions comprising meloxicam

Publications (1)

Publication Number Publication Date
MX2017010304A true MX2017010304A (es) 2018-06-19

Family

ID=60389519

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017010304A MX2017010304A (es) 2015-11-25 2016-04-11 Composiciones farmaceuticas que comprenden meloxicam.
MX2021003230A MX2021003230A (es) 2015-11-25 2017-08-09 Composiciones farmaceuticas que comprenden meloxicam.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021003230A MX2021003230A (es) 2015-11-25 2017-08-09 Composiciones farmaceuticas que comprenden meloxicam.

Country Status (14)

Country Link
EP (2) EP4008319A1 (es)
JP (5) JP6746612B2 (es)
KR (2) KR102429352B1 (es)
CN (2) CN113144218A (es)
CA (1) CA3204396A1 (es)
DK (1) DK3256138T3 (es)
ES (1) ES2913288T3 (es)
HK (1) HK1243650A1 (es)
HU (1) HUE058677T2 (es)
LT (1) LT3256138T (es)
MX (2) MX2017010304A (es)
PL (1) PL3256138T3 (es)
RS (1) RS63260B1 (es)
SI (1) SI3256138T1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102429352B1 (ko) * 2015-11-25 2022-08-03 액섬 테라퓨틱스, 인크. 멜록시캄을 포함하는 약학 조성물
CA3213549A1 (en) 2019-02-06 2020-08-13 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
JP7495340B2 (ja) 2020-12-16 2024-06-04 株式会社ファンケル カルノシン酸含有固体組成物及びカルノシン酸の溶出促進方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005199A1 (de) 1994-08-12 1996-02-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazopyridinsalz
ES2201112T3 (es) 1994-08-13 2004-03-16 Yuhan Corporation Nuevos derivados de pirimidina y procedimientos para su preparacion.
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
AU750125B2 (en) * 1997-08-27 2002-07-11 Hexal Ag New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
EP2260837A1 (en) * 2001-06-01 2010-12-15 Pozen, Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
GB0320382D0 (en) * 2003-08-30 2003-10-01 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Pharmaceutical compositions
CA2554271A1 (en) * 2004-02-10 2005-08-25 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
EP1744757A4 (en) * 2004-05-04 2009-04-22 Equitech Corp IMPROVED ENHANCED COMPOSITION
US20070154542A1 (en) * 2005-12-30 2007-07-05 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
KR20090127870A (ko) * 2007-01-19 2009-12-14 다케다 파마슈티칼스 노쓰 어메리카, 인코포레이티드 크산틴 산화환원효소 저해제들 및 항염증제들을 사용하여 통풍 발열을 방지하거나 또는 통풍 발열의 회수를 감소시키는 방법
CA2685331C (en) * 2007-04-27 2016-07-05 Cydex Pharmaceuticals, Inc. Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
AU2008265595B2 (en) * 2007-06-20 2014-12-04 PureTech LYT 100 Inc. Substituted N-Aryl pyridinones as fibrotic inhibitors
KR20190071006A (ko) * 2009-05-13 2019-06-21 사이덱스 파마슈티칼스, 인크. 프라수그렐 및 사이클로덱스트린 유도체를 포함하는 약학 조성물 및 그의 제조 및 사용 방법
EP4190327A1 (en) * 2010-10-21 2023-06-07 Rtu Pharmaceuticals LLC Ready to use ketorolac formulations
CN102526058A (zh) * 2010-12-28 2012-07-04 秦引林 一种含氯诺昔康和埃索美拉唑消炎镇痛药物组合物
WO2014161131A1 (en) * 2013-04-01 2014-10-09 Arissa Pharma PREPARING AMORPHOUS MELOXICAM-β-CYCLODEXTRIN INCLUSION COMPLEX VIA SPRAY DRYING PROCESS
KR102429352B1 (ko) * 2015-11-25 2022-08-03 액섬 테라퓨틱스, 인크. 멜록시캄을 포함하는 약학 조성물

Also Published As

Publication number Publication date
KR20220110869A (ko) 2022-08-09
MX2021003230A (es) 2022-08-18
CN107405359B (zh) 2021-04-20
JP2018508570A (ja) 2018-03-29
CN113144218A (zh) 2021-07-23
JP2023133545A (ja) 2023-09-22
JP7332202B2 (ja) 2023-08-23
EP4008319A1 (en) 2022-06-08
JP2019131596A (ja) 2019-08-08
DK3256138T3 (da) 2022-05-16
CA3204396A1 (en) 2016-08-18
HUE058677T2 (hu) 2022-09-28
KR102447080B1 (ko) 2022-09-23
RS63260B1 (sr) 2022-06-30
EP3256138A4 (en) 2019-10-02
EP3256138B1 (en) 2022-02-23
JP2022040370A (ja) 2022-03-10
LT3256138T (lt) 2022-06-10
HK1243650A1 (zh) 2018-07-20
CN107405359A (zh) 2017-11-28
JP6746612B2 (ja) 2020-08-26
EP3256138A2 (en) 2017-12-20
KR102429352B1 (ko) 2022-08-03
SI3256138T1 (sl) 2022-07-29
PL3256138T3 (pl) 2022-08-01
ES2913288T3 (es) 2022-06-01
KR20210111333A (ko) 2021-09-10
JP2021066749A (ja) 2021-04-30
JP7017275B2 (ja) 2022-02-08
JP6842122B2 (ja) 2021-03-17

Similar Documents

Publication Publication Date Title
NZ734233A (en) Pharmaceutical compositions comprising meloxicam
MX2021014509A (es) Composiciones farmaceuticas que comprenden meloxicam.
MX2020014128A (es) Composiciones farmaceuticas que comprenden meloxicam.
AU2018256640A1 (en) Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
MA39986A (fr) Dérivés de purine en tant qu'inhibiteurs de cd73 pour le traitement du cancer
CA2956871C (en) Compounds active towards bromodomains
MY187047A (en) Selective pyy compounds and uses thereof
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
CL2015002897A1 (es) Inhibidores de bace1
IN2013MU03583A (es)
IN2013MU00711A (es)
CY1119532T1 (el) (s)-πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη
MX2016015261A (es) Dispersion solida de allisartan isoproxilo y su composicion.
MX2021003230A (es) Composiciones farmaceuticas que comprenden meloxicam.
CY1119522T1 (el) (r)- πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη
MX2015013151A (es) Métodos de tratamiento de disquinesia y trastornos relacionados.
EP3659597A3 (en) Compositions and methods for drug sensitization of parasites
BR112017014295A2 (pt) composição farmacêutica.
IN2014MU00043A (es)
MX365096B (es) Uso de paricalcitol en el tratamiento de la anemia inflamatoria.
UA106905U (uk) Фармацевтична композиція
IN2014MU00077A (es)
IN2014CH01195A (es)
IN2013MU03656A (es)
UA88138U (ru) Лекарственное средство в форме перорального раствора для лечения и профилактики ишемии тканей организма